Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT01929460
Eligibility Criteria:
Inclusion Criteria:
* Patients between the age of 18-90 who present for an EUS / pancreas cyst evaluation
Exclusion Criteria:
* Patients outside the age range
* Patient-related factors (unable to provide consent, unable to understand English, allergic to cipro)
* High-risk patients for infective endocarditis
* Bacterial infection or use of antibiotics within 6 weeks of EUS
* Pancreatitis within the past 6 months
* Underlying immunosuppression (for example, uncontrolled diabetes - such as hemoglobin A1c above 7 or glucose \> 180; renal failure; cirrhosis; pre-existing malignancy especially hematologic malignancy such as leukemia / lymphoma / multiple myeloma; HIV/AIDS)
* Currently taking immunosuppressive medications (for conditions such as rheumatoid arthritis, inflammatory bowel disease, organ transplant)
* Radiographic or endosonographic evidence of cyst cavity debris / necrotic debris
* Severe systemic disease (for example, NYHA class III or IV heart failure, oxygen-dependent COPD)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT01929460
Study Brief:
Protocol Section:
NCT01929460